Regenexx

Regenexx has published numerous studies—including randomized controlled trials—demonstrating that its proprietary bone marrow concentrate and platelet-based injection protocols can reduce pain and improve function in patients with orthopedic conditions such as knee arthritis, rotator cuff tears, ACL injuries, and degenerative disc disease. The company claims to have published roughly half of all global research on bone marrow concentrate for orthopedic use. Its Percutaneous ACL Repair procedure has shown mid-term results helping patients avoid surgical reconstruction. Safety data from large patient registries have also been published.